feedback

Provider Statement

This continuing medical education activity is provided by

Support Statement

This activity is supported by an educational grant from Teva Pharmaceuticals.

Activity Chair

Fahd Amjad, MD, MS
Fahd Amjad, MD, MS
Assistant Professor, Department of Neurology
Movement Disorder Division,
Medstar Georgetown University Hospital
Co-Clinical Director,
Huntington Disease Care Education and Research Center
Washington, D.C.

Disclosures:
Consulting Fee: Abbvie, Lundbeck, Merz, Teva, UCB


Faculty

Karen E.  Anderson, MD
Karen E. Anderson, MD
Associate Professor, Neurology and Psychiatry
HDCERC Director, Medstar
Georgetown University Hospital
Washington, D.C.

Disclosures:
Consulting Fee: Azevan, Prana, Teva
Speakers Bureau: Lundbeck
Contracted Research: Teva
Grant Support: Auspex, Teva
Travel Grant: Prana


Vicki L. Wheelock, MD
Vicki L. Wheelock, M.D.
Clinical Professor
Specialty: Neurology
Director, Huntington’s Disease Clinic
Site Investigator, Huntington Study Group

Disclosures:
No relevant financial relationships to disclose.


Reviewers
Daniel Claassen, MD
Disclosures:
Consulting Fee: AbbVie, Acadia, Auspex, Lundbeck, Teva
Speakers Bureau: Lundbeck
Contracted Research: CHDI, Michael J Fox Foundation, NIH/NINDS, Teva

Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
Disclosures: No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, May 11, 2016 to May 10, 2017.

How to Participate in this Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, read the articles, complete the CME posttest, and complete and return the registration form and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 out of 3 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Overview

Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system (CNS) characterized by abnormal involuntary movements, behavioral disturbance, cognitive dysfunction, and psychiatric disease. Currently, there is no established treatment to delay the onset or prevent the progression of HD, and available pharmacologic interventions for controlling the motor and non-motor aspects of the disease are limited. However, recent therapeutic advances, particularly in suppressing chorea, have been shown to have a favorable effect on motor function, safety, and quality of life. In this roundtable discussion, recorded immediately after the 2016 AAN Annual Meeting in Vancouver, BC, Canada, leading experts in HD explore some of the most recent evidence and latest developments in the treatment for this devastating disease.

Target Audience

The intended audience for the activity is neurologists, psychiatrists, and other health care professionals involved in the treatment of patients with HD.

Learning Objectives

Upon successful completion of the activity, participants should be better able to:

  • Review the latest clinical data regarding available and emerging agents for the management of chorea and other symptoms associated with HD.
  • Differentiate available and emerging agents for the management of HD based on mechanism of action, safety, efficacy, and recommended usage.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2016 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.